Compound Summary
Compound Name: | formoterol |
Compound CID: | 3410 |
Synonyms: | formoterol 73573-87-2 Formoterolum INN-Latin n-2-hydroxy-5-(1-hydroxy-2-{1-(4-methoxyphenyl)propan-2-ylamino}ethyl)phenylformamide N-2-hydroxy-5-1-hydroxy-2-1-(4-methoxyphenyl)propan-2-ylaminoethylphenylformamide More... |
Iupac Name: | N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide |
InChI: | InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22) |
InChIKey: | BPZSYCZIITTYBL-UHFFFAOYSA-N |
Canonical Smiles: | CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O |
Isomeric Smiles: | CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O |
Molecular Weight: | 344.4 |
Molecular Formula: | C19H24N2O4 |
Molecular Weight: | 344.4 |
Molecular Formula: | C19H24N2O4 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 8 |
Heavy Atom Count: | 25 |
Complexity: | 388 |
formoterol | formoterol |
---|---|
formoterol |
73573-87-2 |
Formoterolum INN-Latin |
n-2-hydroxy-5-(1-hydroxy-2-{1-(4-methoxyphenyl)propan-2-ylamino}ethyl)phenylformamide |
N-2-hydroxy-5-1-hydroxy-2-1-(4-methoxyphenyl)propan-2-ylaminoethylphenylformamide |
128954-45-0 |
Formoterol (mixture of Diastereomers) |
FORMOTEROL FUMARATE |
CHEBI:63082 |
2-hydroxy-5-(1-hydroxy-2-((p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide" |
2-hydroxy-5-{1-hydroxy-2-(p-methoxy-alpha-methylphenethyl)aminoethyl}formanilide |
N-2-hydroxy-5-(1-hydroxy-2-{2-(4-methoxyphenyl)-1-methylethylamino}ethyl)phenylformamide |
Formoterol (INN) |
Oxis (TN) |
Oxeze/Oxis |
BD-40A |
CGP-25827A |
NCGC00181126-01 |
SCHEMBL349579 |
GTPL3465 |
CHEMBL1256786 |
SCHEMBL15856256 |
BDBM86453 |
AC-459 |
STL450992 |
AKOS015961179 |
AT22502 |
DB00983 |
SB17482 |
VA10968 |
NSC_3083544 |
AS-14186 |
K252 |
AB0014121 |
CAS_73573-87-2 |
Formoterol Fumarate Dihydrate EP Impurity I |
C07805 |
D07990 |
L000259 |
Q637247 |
126587-85-7 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | 2.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 2.000000000000000 | 1 | 1 |